New Drugs in JDM Virtual Symposium

October 17, 2020

Learning Objectives

  • Appreciate the importance of new drug development in juvenile dermatomyositis
  • Understand developments in knowledge of disease pathogenesis that impacts drug development
  • Describe the roles of the three medications presented in the treatment of juvenile dermatomyositis
  • Increase participation in available clinical trials relevant in treatment of juvenile dermatomyositis
Course summary
Available credit: 
  • 2.50 AMA PRA Category 1 Credit(s)
  • 2.50 ANCC
  • 2.50 Attendance
  • 2.50 JA Credit - AH
    • 2.50 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
10/17/2020
Registration Expires: 
10/16/2021
Activity Starts: 
10/17/2020 - 11:00am
Activity Ends: 
10/17/2020 - 3:00pm
Rating: 
0
Duke University Health System-Virtual
Durham, NC 27710
United States

Available Credit

  • 2.50 AMA PRA Category 1 Credit(s)
  • 2.50 ANCC
  • 2.50 Attendance
  • 2.50 JA Credit - AH
    • 2.50 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.